<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mann, Kate</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Hering, Bernhard J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Human Islet Cell Transplantation Successful in Patients with Type 1 Diabetes Who Have SH</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-13</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses preliminary data from the Islet Transplantation in Type 1 Diabetes study [NCT00434811]. The Phase 3, open-label, single-group study was conducted by the Clinical Islet Transplantation (CIT) Consortium. The CIT was created by the National Institutes of Health to advance islet transplantation for patients with type 1 diabetes mellitus and severe hypoglycemia and patients who have had a kidney transplant.</style></abstract><number><style face="normal" font="default" size="100%">19</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>